Microsporidiosis

Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD's weight loss doctor NYC
Philadelphia GLP-1 weight loss and GLP-1 clinic NYC

Microsporidiosis
Synonyms	N/A
Pronounce	N/A
Specialty	N/A
Symptoms	Diarrhea, abdominal pain, weight loss, fever
Complications	Malabsorption, dehydration
Onset	Variable, often acute
Duration	Can be chronic in immunocompromised individuals
Types	N/A
Causes	Infection by Microsporidia
Risks	Immunocompromised status, HIV/AIDS, organ transplantation
Diagnosis	Microscopy, PCR, biopsy
Differential diagnosis	Cryptosporidiosis, Giardiasis, Amebiasis
Prevention	Safe drinking water, hand hygiene
Treatment	Albendazole, Fumagillin
Medication	N/A
Prognosis	Generally good in immunocompetent individuals
Frequency	More common in developing countries
Deaths	N/A

Microsporidiosis is an infection caused by microsporidia, a group of spore-forming unicellular parasites. These organisms are known to infect a wide range of hosts, including humans, and are particularly significant in immunocompromised individuals.

Etiology

Microsporidiosis is caused by various species of microsporidia, with the most common human pathogens being Enterocytozoon bieneusi and Encephalitozoon intestinalis. These organisms are obligate intracellular parasites, meaning they must live within the cells of their host to survive and reproduce.

Transmission

The primary mode of transmission of microsporidiosis is through the ingestion of spores, which can be found in contaminated food and water. Person-to-person transmission can also occur, particularly in settings with poor sanitation. In addition, zoonotic transmission from animals to humans has been documented.

Pathogenesis

Once ingested, the spores of microsporidia infect the epithelial cells of the gastrointestinal tract. The spores extrude a polar tubule that penetrates the host cell membrane, allowing the parasite to inject its sporoplasm into the host cell. Inside the host cell, the microsporidia replicate and eventually cause cell lysis, releasing new spores to infect other cells.

Clinical Manifestations

The clinical presentation of microsporidiosis can vary depending on the species involved and the immune status of the host. In immunocompetent individuals, the infection may be asymptomatic or cause mild, self-limiting gastrointestinal symptoms such as diarrhea. In immunocompromised individuals, such as those with HIV/AIDS or undergoing immunosuppressive therapy, the infection can be more severe and disseminate to other organs, causing symptoms such as:

• Chronic diarrhea
• Malabsorption
• Weight loss
• Hepatitis
• Sinusitis
• Keratoconjunctivitis

Diagnosis

Diagnosis of microsporidiosis typically involves the identification of microsporidia spores in stool samples, urine, or tissue biopsies. Techniques used for diagnosis include:

• Light microscopy with special stains (e.g., modified trichrome stain)
• Electron microscopy
• Polymerase chain reaction (PCR) assays

Treatment

The treatment of microsporidiosis depends on the species involved and the immune status of the patient. Commonly used medications include:

• Albendazole: Effective against Encephalitozoon species.
• Fumagillin: Used for infections caused by Enterocytozoon bieneusi.

In immunocompromised patients, improving immune function through antiretroviral therapy (in the case of HIV/AIDS) can also help control the infection.

Prevention

Preventive measures for microsporidiosis include:

• Ensuring access to clean water and proper sanitation
• Practicing good hygiene, such as handwashing
• Avoiding consumption of potentially contaminated food and water

Epidemiology

Microsporidiosis is a global disease, with higher prevalence in areas with poor sanitation and among immunocompromised populations. The true prevalence is likely underreported due to the difficulty in diagnosing the infection.

See Also

• Parasitic disease
• Opportunistic infection
• Immunocompromised host